Exhibit 10.2 - Revised Bridge Loan
Agreement, dated May 7, 1999,
between the Company and eBanker
XXX.xxx, Inc.
eBanker XXX.xxx, Inc.
0000 Xxxxxxx Xxxxxx
00xx Xxxxx
Xxxxxx, Xxxxxxxx 00000
May 7, 1999
Xxxxxxx X. Xxxxx, M.D.
Global Med Technologies, Inc.
00000 Xxxx Xxxxxx
Xxxxx X-000
Xxxxxxxx, XX 00000
Re: Revised $750,000 Bridge Loan - Convertible into Common Stock of Global
Med Technologies, Inc.
Dear Mick:
This agreement supersedes, in its entirety, my letter dated March 18, 1999, to
you relating to a $750,000 Bridge Loan and confirms our oral extension of our
commitment.
eBanker hereby commits to loan to Global Med Technologies, Inc. (Global) Seven
Hundred Fifty Thousand Dollars ($750,000) on or before October 15, 1999. The
loan will bear interest at the rate of 12% per annum which shall be payable
monthly.
The full amount of principal and any unpaid accrued interest will be due and
payable on or before December 31, 1999. Until paid in full, the principal
balance of and any unpaid accrued interest on the loan may be converted, at the
option of eBanker, into Global Common Stock at the average closing bid price of
Global common stock for 15 days prior to the date of conversion.
As consideration for the commitment for the Bridge Loan, Global shall pay
eBanker a 2% commitment fee of $15,000 payable in 13,275 shares of Global common
stock, which was determined using the $1.13 average closing bid price for 15
days prior to April 15, 1999.
Any amounts outstanding under this Bridge Loan at the time of the closing of any
future Global private or public offering of securities shall be paid, including
outstanding interest, from proceeds from the private or public offering of
securities, although, this may be prior to December 31, 1999.
Very truly yours, For and on behalf of eBanker XXX.xxx, Inc.
By: /s/ Xxx X. Xxxx /s/ Xxxxxx X. Xxxxx
------------------------- --------------------------------
Xxx X. Xxxx Xxxxxx X. Xxxxx
Chairman Secretary
Accepted:
Global Med Technologies, Inc.
By: /s/ Xxxxxxx X. Xxxxx
-------------------------
Xxxxxxx X. Xxxxx, M.D.
Chairman and CEO
